About Team Portfolio Get in Touch →
Early & Mid-Stage Venture Capital

Investing in a
healthier world

Other Strategic Investors backs pioneering companies at the intersection of biotech and AI — funding the science, technology, and teams that will define the future of human health.

View Portfolio Contact Us
Biotech
Focus Area
AI
Focus Area
Early & Mid
Stage
About

Capital with
conviction

We partner with founders who believe innovation is the most powerful tool for improving human health. From discovery-stage biotech to AI-driven diagnostics, we provide more than capital — we provide deep expertise and long-term commitment.

Early-Stage Bets
We engage when the science is still being written, providing runway and strategic guidance to help founders prove out bold hypotheses.
Mid-Stage Acceleration
As portfolio companies approach clinical milestones or commercial launch, we double down with capital and network to accelerate growth.
Mission-Driven Returns
We believe the best financial outcomes flow from companies solving the world's most important problems — beginning with health.
Our Team

Built from diverse
expertise

Healthcare
Deep roots in clinical medicine, biopharma, and the business of healthcare delivery.
Artificial Intelligence
Hands-on experience building and deploying machine learning systems across life sciences.
Accounting & Finance
Rigorous financial analysis and governance expertise that supports sound capital deployment.
Real Estate
Perspective on asset valuation, market cycles, and long-horizon capital allocation.
Our principals bring together a rare combination of domain expertise that spans the full lifecycle of a company — from early scientific validation to commercial-stage growth. This multidisciplinary foundation allows us to evaluate opportunities others may overlook and to support our founders with insight drawn from multiple industries.
Portfolio

Companies we believe in

We invest in founders building the next generation of health innovation — from cutting-edge therapeutics to transformative medical devices.

Medical Devices · Oncology
HistoSonics

HistoSonics is pioneering histotripsy — a non-invasive sonic beam therapy that uses focused sound energy to precisely destroy tumors at the sub-cellular level without incisions or needles. Their FDA-cleared Edison System is transforming how liver tumors and metastases are treated, with clinical expansion planned into kidney, pancreatic, and prostate cancers.

Non-invasive oncology FDA Cleared
Medical Devices · Orthopedics
Bloom Biomedical

Bloom Biomedical is developing a minimally invasive interbody fusion implantation technology platform designed to improve orthopedic surgical care. Their novel integrated bone access and resection system allows surgeons to approach joint spaces with minimal disruption to surrounding soft tissue — improving surgical efficiency, reducing procedural burden, and accelerating patient recovery.

Minimally invasive Orthopedic surgery
Contact

Let's talk

We're always open to meeting exceptional founders, researchers, and co-investors working at the frontier of biotech and AI. Reach out to start a conversation.

info@otherstrategicinvestors.com